European heart journal. Cardiovascular Imaging · 2026
Factors associated with aortic valve calcification in type 2 diabetes-a Steno INTEN-CT substudy.
СтатьяМногоцентровое исследованиеРандомизированное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Haujir Amal, Kumarathurai Preman, Stidsen Jacob Volmer, Poulsen Per Løgstrup, Funck Kristian Løkke, Mohammad Batool J Y, Ravn Emil Johannes, Hasific Selma, Engelsgaard Camilla, Ramanathan Ramshanker, Madsen Lene Helleskov, Hansen Monija Mrgan, Böttcher Morten, Pietraszek Anna, Olsen Michael Hecht, Kofoed Klaus Fuglsang, Karon Marek, Hansen Tine Willum, Eskesen Kristian, Calderon Elena, Lambrechtsen Jess, Clavel Marie-Annick, Øvrehus Kristian Altern, Diederichsen Axel C P, Dahl Jordi S
Аннотация
AIMS: This study aimed to identify clinical factors associated with AVC in individuals with T2D.
METHODS AND RESULTS: This cross-sectional study is a pre-specified substudy of the multicentre randomized Steno INTEN-CT trial (Clinical Trials-INTEN-CT). Participants were eligible if they had T2D without ischaemic heart disease and were aged between 55-69 years (men) or 60-74 years (women). All participants underwent non-contrast cardiac computed tomography. AVC was measured in Agatston Units and categorized as 0, 0-300, ≥ 300. Of the 4570 participants, 46% had AVC > 0. With increasing AVC, patients were older, predominantly males, and with significantly more comorbidities. In multivariable ordered logistic regression age (OR per SD 1.54, 95% CI 1.43-1.66), BMI (OR per SD 1.18, 95% CI 1.11-1.25), hypertension (OR 1.21, 95% CI 1.05-1.40), and chronic kidney disease (OR 1.18, 95% CI 1.03-1.36) were associated with higher AVC. Statin use was also associated with higher AVC (OR 1.50, 95% CI 1.27-1.78). Higher LDL cholesterol showed stronger associations with AVC in men than women (OR 1.39, 95% CI 1.24-1.56 vs. OR 1.16, 95% CI 1.02-1.31, P for interaction = 0.025). T2D severity (Haemoglobin A1c, T2D duration, and number of antidiabetic drugs) was not associated with AVC.
CONCLUSION: In individuals with T2D without cardiovascular disease, AVC is prevalent in nearly half of all individuals. Higher AVC was associated with T2D-related comorbidities, but not T2D severity.
METHODS AND RESULTS: This cross-sectional study is a pre-specified substudy of the multicentre randomized Steno INTEN-CT trial (Clinical Trials-INTEN-CT). Participants were eligible if they had T2D without ischaemic heart disease and were aged between 55-69 years (men) or 60-74 years (women). All participants underwent non-contrast cardiac computed tomography. AVC was measured in Agatston Units and categorized as 0, 0-300, ≥ 300. Of the 4570 participants, 46% had AVC > 0. With increasing AVC, patients were older, predominantly males, and with significantly more comorbidities. In multivariable ordered logistic regression age (OR per SD 1.54, 95% CI 1.43-1.66), BMI (OR per SD 1.18, 95% CI 1.11-1.25), hypertension (OR 1.21, 95% CI 1.05-1.40), and chronic kidney disease (OR 1.18, 95% CI 1.03-1.36) were associated with higher AVC. Statin use was also associated with higher AVC (OR 1.50, 95% CI 1.27-1.78). Higher LDL cholesterol showed stronger associations with AVC in men than women (OR 1.39, 95% CI 1.24-1.56 vs. OR 1.16, 95% CI 1.02-1.31, P for interaction = 0.025). T2D severity (Haemoglobin A1c, T2D duration, and number of antidiabetic drugs) was not associated with AVC.
CONCLUSION: In individuals with T2D without cardiovascular disease, AVC is prevalent in nearly half of all individuals. Higher AVC was associated with T2D-related comorbidities, but not T2D severity.